{"id":"alternating-chemotherapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Cardiotoxicity"}]},"_chembl":{"chemblId":"CHEMBL4297950","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach involves rotating between distinct chemotherapy drugs with different mechanisms of action and resistance profiles, administered in alternating cycles. By switching agents, the regimen aims to prevent the development of cross-resistant tumor clones and maximize cytotoxic effect while potentially reducing cumulative toxicity from any single agent.","oneSentence":"Alternating chemotherapy uses sequential administration of different chemotherapeutic agents to overcome drug resistance and improve treatment efficacy.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:01:01.884Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute leukemia (likely acute myeloid leukemia, based on PETHEMA Foundation focus)"}]},"trialDetails":[{"nctId":"NCT07495631","phase":"NA","title":"Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Acute Lymphoblastic Leukemia, Adult","enrollment":80},{"nctId":"NCT02567435","phase":"PHASE3","title":"Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-06-01","conditions":"Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma","enrollment":325},{"nctId":"NCT07444710","phase":"PHASE1","title":"Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-08-20","conditions":"Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma, Ann Arbor Stage IV Mantle Cell Lymphoma","enrollment":16},{"nctId":"NCT07205718","phase":"PHASE1, PHASE2","title":"A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-11-19","conditions":"Advanced or Metastatic Solid Tumors","enrollment":223},{"nctId":"NCT05108870","phase":"PHASE1, PHASE2","title":"TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers","status":"NOT_YET_RECRUITING","sponsor":"University of Chicago","startDate":"2026-07-17","conditions":"Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma","enrollment":98},{"nctId":"NCT05990426","phase":"NA","title":"Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2023-10-16","conditions":"Ovary Cancer, Endometrial Cancer, Uterine Cancer","enrollment":30},{"nctId":"NCT07194044","phase":"PHASE1","title":"Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2026-02","conditions":"Metastatic Ewing Sarcoma","enrollment":15},{"nctId":"NCT05581030","phase":"PHASE1","title":"CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2023-05-01","conditions":"Acute Lymphoblastic Leukemia","enrollment":7},{"nctId":"NCT07454226","phase":"NA","title":"ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Ph-Like, Acute Lymphoblastic Leukemia","enrollment":30},{"nctId":"NCT07294677","phase":"PHASE1, PHASE2","title":"CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2026-03-17","conditions":"Leukemia, Lymphoma","enrollment":104},{"nctId":"NCT06789003","phase":"NA","title":"Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible for Intensive Autologous Stem Cell Transplantation Treatment","status":"RECRUITING","sponsor":"Centre Hospitalier Henri Duffaut - Avignon","startDate":"2025-02-10","conditions":"Multiple Myeloma","enrollment":120},{"nctId":"NCT07446387","phase":"PHASE2","title":"A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Cancer Institute & Hospital","startDate":"2026-02-01","conditions":"Metastatic Colorectal Cancer (CRC)","enrollment":70},{"nctId":"NCT04469530","phase":"PHASE2","title":"Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors","status":"RECRUITING","sponsor":"Emory University","startDate":"2020-09-16","conditions":"Solid Tumor","enrollment":55},{"nctId":"NCT03203525","phase":"PHASE1","title":"Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-06-23","conditions":"Advanced Malignant Neoplasm, Colorectal Carcinoma Metastatic in the Liver, Metastatic Malignant Neoplasm in the Liver","enrollment":38},{"nctId":"NCT00352534","phase":"PHASE3","title":"Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2006-11-06","conditions":"Stage I Kidney Wilms Tumor, Stage II Kidney Wilms Tumor, Stage III Kidney Wilms Tumor","enrollment":808},{"nctId":"NCT06601621","phase":"NA","title":"Study on the Impact of Electroacupuncture Combined With Self-Acupressure on the Quality of Life of Patients With Early-Stage Breast Cancer Undergoing Chemotherapy","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2024-10-19","conditions":"Electroacupuncture, Quality of Life (QOL), Acupressure","enrollment":192},{"nctId":"NCT04994717","phase":"PHASE3","title":"Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Amgen","startDate":"2021-11-02","conditions":"Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)","enrollment":304},{"nctId":"NCT03875144","phase":"PHASE2","title":"Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)","status":"SUSPENDED","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2020-09-10","conditions":"Peritoneal Mesothelioma, Peritoneal Carcinomatosis","enrollment":66},{"nctId":"NCT04587128","phase":"PHASE2","title":"Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2020-10-19","conditions":"Metastatic Colorectal Cancer","enrollment":34},{"nctId":"NCT05139095","phase":"PHASE2","title":"Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2022-01-27","conditions":"Gestational Trophoblastic Neoplasia","enrollment":70},{"nctId":"NCT07172204","phase":"PHASE2","title":"Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-09-16","conditions":"Intensive Chemotherapy Unfit, Newly Diagnosed Acute Myeloid Leukemia (AML), Age ≥60","enrollment":25},{"nctId":"NCT05847569","phase":"PHASE2","title":"Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-01-04","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":62},{"nctId":"NCT06313203","phase":"PHASE2","title":"HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2024-02-13","conditions":"Intrahepatic Cholangiocarcinoma, Chemotherapy Effect","enrollment":39},{"nctId":"NCT07372443","phase":"NA","title":"Photobiomodulation in the Prevention and Management of Oral Mucositis in Children","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Guanajuato","startDate":"2026-01","conditions":"Oral Mucositis, Chemotherapy Effect, Pediatric Cancer","enrollment":49},{"nctId":"NCT07351773","phase":"NA","title":"Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease","status":"COMPLETED","sponsor":"Taizhou Second People's Hospital","startDate":"2025-01-26","conditions":"Alzheimer's Disease(AD), Cognitive Dysfunction","enrollment":40},{"nctId":"NCT05826964","phase":"PHASE2","title":"Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2023-06-12","conditions":"Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer","enrollment":24},{"nctId":"NCT07333976","phase":"PHASE2","title":"o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer","status":"COMPLETED","sponsor":"Tri-Service General Hospital","startDate":"2020-01-05","conditions":"Prostate Cancer Metastatic Disease, Chemotherapy Induced Peripheral Neuropathy (CIPN), Neurotoxicity","enrollment":90},{"nctId":"NCT07187466","phase":"PHASE4","title":"Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Overactive Bladder, Parkinson Disease","enrollment":146},{"nctId":"NCT05332002","phase":"PHASE2","title":"sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2022-07-13","conditions":"Gastro-Intestinal Cancer","enrollment":38},{"nctId":"NCT02870907","phase":"PHASE2","title":"Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Curie","startDate":"2010-03-18","conditions":"Retinoblastoma","enrollment":195},{"nctId":"NCT07319910","phase":"","title":"Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"NovoCure GmbH","startDate":"","conditions":"Locally Advanced Pancreatic Adenocarcinoma","enrollment":""},{"nctId":"NCT06625047","phase":"PHASE4","title":"Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2024-10-07","conditions":"Astrocytoma, IDH-Mutant, Glioblastoma, Glioma","enrollment":30},{"nctId":"NCT06085274","phase":"NA","title":"Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-09-03","conditions":"Breast Cancer","enrollment":100},{"nctId":"NCT04198766","phase":"PHASE1, PHASE2","title":"Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Inhibrx Biosciences, Inc","startDate":"2019-12-10","conditions":"Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer","enrollment":296},{"nctId":"NCT07277153","phase":"PHASE4","title":"Clinical Study on the Effect of Tegileridine on Postoperative Pain in Patients Undergoing Abdominal Surgery.","status":"COMPLETED","sponsor":"Xin Chen","startDate":"2025-10-18","conditions":"Laparoscopic Surgery for Cholecystitis","enrollment":150},{"nctId":"NCT07277998","phase":"NA","title":"Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis","status":"NOT_YET_RECRUITING","sponsor":"Karachi Medical and Dental College","startDate":"2026-03","conditions":"Oral Submucous Fibrosis","enrollment":40},{"nctId":"NCT05564650","phase":"PHASE1","title":"Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2023-01-12","conditions":"Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome","enrollment":6},{"nctId":"NCT02066220","phase":"PHASE2, PHASE3","title":"International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2014-06","conditions":"Brain Tumors","enrollment":360},{"nctId":"NCT06532552","phase":"PHASE2","title":"Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2024-07-29","conditions":"Acute Myeloid Leukemia, Adult, Newly Diagnosed","enrollment":172},{"nctId":"NCT07043270","phase":"PHASE2","title":"24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC","status":"RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2025-09-29","conditions":"Pancreas Adenocarcinoma","enrollment":35},{"nctId":"NCT07185451","phase":"NA","title":"Efficacy and Safety of Transcranial Alternating Current Stimulation (tACS) Combined With Stable Medication in Adolescents With Depression: A Randomized, Double-Blind, Controlled Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2025-10-01","conditions":"Depression - Major Depressive Disorder","enrollment":30},{"nctId":"NCT02858999","phase":"PHASE2","title":"Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2010-01","conditions":"Multiple Myeloma","enrollment":40},{"nctId":"NCT03004287","phase":"PHASE2","title":"2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Arkansas","startDate":"2017-07-01","conditions":"Multiple Myeloma","enrollment":50},{"nctId":"NCT00186888","phase":"PHASE3","title":"Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2005-04-07","conditions":"Retinoblastoma, Retinal Neoplasm","enrollment":107},{"nctId":"NCT06023641","phase":"PHASE2","title":"Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-03-13","conditions":"Rhabdomyosarcoma","enrollment":135},{"nctId":"NCT06889025","phase":"NA","title":"Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen","status":"NOT_YET_RECRUITING","sponsor":"Felicia Iftene","startDate":"2025-07-24","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":28},{"nctId":"NCT07062536","phase":"PHASE2","title":"mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2025-08-01","conditions":"Biliary Cancer Metastatic","enrollment":130},{"nctId":"NCT07059156","phase":"PHASE2, PHASE3","title":"Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-06-01","conditions":"Acute Lymphoblastic Leukemia, Adult","enrollment":50},{"nctId":"NCT04115007","phase":"PHASE3","title":"Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2020-06-23","conditions":"Oligometastatic Hormone Sensitive Prostate Cancer","enrollment":550},{"nctId":"NCT05985824","phase":"NA","title":"The Effect of Pranayama Breathing Exercise on Quality of Life in Lung Cancer Patients","status":"COMPLETED","sponsor":"Sanko University","startDate":"2023-01-06","conditions":"Lung Cancer","enrollment":72},{"nctId":"NCT04990609","phase":"PHASE2","title":"EUS-RFA PANCARDINAL-1 Trial","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-08-13","conditions":"Pancreatic Ductal Adenocarcinoma (PDAC)","enrollment":60},{"nctId":"NCT04478292","phase":"PHASE3","title":"A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy","status":"RECRUITING","sponsor":"Shanghai Children's Medical Center","startDate":"2021-03-01","conditions":"Hepatoblastoma","enrollment":330},{"nctId":"NCT06948058","phase":"NA","title":"Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy","status":"RECRUITING","sponsor":"Brown University","startDate":"2025-04-01","conditions":"Smoking Cessation, Obesity and Obesity-related Medical Conditions","enrollment":60},{"nctId":"NCT03500133","phase":"PHASE4","title":"Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.","status":"RECRUITING","sponsor":"Hospital JP Garrahan","startDate":"2017-10-06","conditions":"Pediatric Hodgkin's Disease","enrollment":500},{"nctId":"NCT04474964","phase":"NA","title":"Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.","status":"RECRUITING","sponsor":"Tata Memorial Centre","startDate":"2020-08-13","conditions":"Medulloblastoma, WNT-activated","enrollment":30},{"nctId":"NCT06377228","phase":"PHASE1","title":"A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)","status":"WITHDRAWN","sponsor":"Takeda","startDate":"2025-06-13","conditions":"Refractory Lupus Nephritis, Refractory Systemic Sclerosis","enrollment":""},{"nctId":"NCT05303792","phase":"PHASE2","title":"Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2023-06-09","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma","enrollment":68},{"nctId":"NCT06200168","phase":"PHASE3","title":"Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2024-01-16","conditions":"Electroacupuncture, Olanzapine-contained Four-drug Antiemetic, Nausea and Vomiting","enrollment":370},{"nctId":"NCT04553692","phase":"PHASE1","title":"Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers","status":"TERMINATED","sponsor":"IGM Biosciences, Inc.","startDate":"2020-09-23","conditions":"Solid Tumor, Colorectal Cancer, Non Hodgkin Lymphoma","enrollment":272},{"nctId":"NCT06266312","phase":"NA","title":"Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer","status":"RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2024-05-27","conditions":"Breast Cancer, Breast Neoplasms","enrollment":11},{"nctId":"NCT06324344","phase":"NA","title":"Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2023-10-02","conditions":"Chemotherapy-induced Peripheral Neuropathy, Pain, Neuropathy","enrollment":10},{"nctId":"NCT04923776","phase":"PHASE2","title":"Liver Directed RT + Chemo-immunotherapy for ES-SCLC","status":"TERMINATED","sponsor":"Brian Henick, MD","startDate":"2021-09-20","conditions":"Small-cell Lung Cancer","enrollment":2},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT01531595","phase":"PHASE2","title":"Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pia Osterlund","startDate":"2012-02","conditions":"Metastatic Colorectal Cancer","enrollment":100},{"nctId":"NCT06699472","phase":"PHASE2","title":"A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-10-31","conditions":"Ewing Sarcoma, Myelosuppression","enrollment":22},{"nctId":"NCT02181413","phase":"PHASE3","title":"A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant","status":"COMPLETED","sponsor":"Takeda","startDate":"2014-07-16","conditions":"Multiple Myeloma, Autologous Stem Cell Transplant","enrollment":656},{"nctId":"NCT04898504","phase":"PHASE2","title":"HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oslo University Hospital","startDate":"2021-08-23","conditions":"Colorectal Cancer, Liver Metastases, Chemotherapy Effect","enrollment":45},{"nctId":"NCT06299917","phase":"NA","title":"WORK-ON Vocational Rehabilitation for People with Inflammatory Arthritis","status":"RECRUITING","sponsor":"The Danish Center for Expertise in Rheumatology","startDate":"2024-03-01","conditions":"Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis","enrollment":56},{"nctId":"NCT05557110","phase":"PHASE2","title":"Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL","status":"COMPLETED","sponsor":"Chen Suning","startDate":"2022-09-08","conditions":"B Acute Lymphoblastic Leukemia","enrollment":35},{"nctId":"NCT06530459","phase":"PHASE2, PHASE3","title":"The MUSE Study for Menopausal Arthralgia","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2024-08-01","conditions":"Arthralgia, Menopause, Perimenopausal Disorder","enrollment":100},{"nctId":"NCT06497062","phase":"PHASE2","title":"Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-09-04","conditions":"Acute Myeloid Leukemia","enrollment":47},{"nctId":"NCT06482684","phase":"PHASE2","title":"CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma","status":"RECRUITING","sponsor":"Christian Schmidt, MD","startDate":"2024-02-15","conditions":"Mantle Cell Lymphoma","enrollment":150},{"nctId":"NCT05395910","phase":"PHASE1","title":"Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2023-08-04","conditions":"Peritoneal Carcinomatosis","enrollment":36},{"nctId":"NCT05765084","phase":"PHASE1, PHASE2","title":"Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2023-02-24","conditions":"Malignant Pleural Mesothelioma","enrollment":15},{"nctId":"NCT02641314","phase":"PHASE2","title":"Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2016-12-22","conditions":"Recurrent Neuroblastoma","enrollment":18},{"nctId":"NCT05228431","phase":"PHASE2","title":"Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Zhen-Hai Lu","startDate":"2022-03-02","conditions":"Advanced Rectal Cancer","enrollment":121},{"nctId":"NCT05358548","phase":"PHASE2","title":"ATATcH Alternating Treatment Plans for Advanced Cancer","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2022-04-28","conditions":"Head and Neck Cancer, Lung Cancer","enrollment":150},{"nctId":"NCT06063421","phase":"NA","title":"Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan","status":"NOT_YET_RECRUITING","sponsor":"Strategic Health Research Limited","startDate":"2024-06-01","conditions":"Smoking Cessation, Electronic Cigarette Use","enrollment":438},{"nctId":"NCT06314906","phase":"PHASE3","title":"Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer","status":"RECRUITING","sponsor":"Feixue Song","startDate":"2024-03-07","conditions":"Electroacupuncture, Olanzapine-contained Four-drug Antiemetic, Nausea and Vomiting","enrollment":370},{"nctId":"NCT04297332","phase":"NA","title":"Episodic Future Thinking and Future Thinking Priming for Smoking Cessation","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2020-01-01","conditions":"Tobacco-Related Carcinoma","enrollment":26},{"nctId":"NCT01527149","phase":"PHASE2","title":"Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2011-12-06","conditions":"Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma","enrollment":37},{"nctId":"NCT03363919","phase":"NA","title":"Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-09-24","conditions":"Major Depressive Disorder","enrollment":47},{"nctId":"NCT04589741","phase":"PHASE2","title":"Toripalimab Combined With CAV/IE Regimen","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2020-10-23","conditions":"Soft Tissue Sarcoma","enrollment":200},{"nctId":"NCT04589754","phase":"PHASE2","title":"Adriamycin and Ifosfamide Combined With Sintilimab","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-07-26","conditions":"Soft Tissue Sarcoma","enrollment":176},{"nctId":"NCT04646733","phase":"NA","title":"Effect of a Low-carbohydrate, High-protein Energy-restricted Diet on Weight and Body Composition Using DXA","status":"COMPLETED","sponsor":"Erik Ramirez Lopez","startDate":"2020-01-13","conditions":"Weight Loss, Body Composition","enrollment":150},{"nctId":"NCT05088889","phase":"PHASE1","title":"Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2022-01-25","conditions":"Stage IV Pancreatic Cancer","enrollment":10},{"nctId":"NCT02728531","phase":"PHASE1","title":"Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2016-04-18","conditions":"Mantle Cell Lymphoma","enrollment":18},{"nctId":"NCT05766215","phase":"NA","title":"Nurse-led Therapeutic Education Effects in Glycemic Control and Knowledge of Type 1 Diabetes Mellitus Patients Under Hospital Transition","status":"UNKNOWN","sponsor":"Hospitales Universitarios Virgen del Rocío","startDate":"2023-09-30","conditions":"Nurse's Role","enrollment":13},{"nctId":"NCT01336933","phase":"PHASE2","title":"Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2011-07-06","conditions":"Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma","enrollment":34},{"nctId":"NCT00101101","phase":"PHASE2","title":"Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2004-07","conditions":"Lymphoma","enrollment":43},{"nctId":"NCT00006734","phase":"PHASE3","title":"Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-05","conditions":"Sarcoma","enrollment":587},{"nctId":"NCT04368988","phase":"PHASE1, PHASE2","title":"Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant","status":"COMPLETED","sponsor":"Novavax","startDate":"2020-05-25","conditions":"COVID-19","enrollment":1419},{"nctId":"NCT04944927","phase":"","title":"HEmiplegia Arrhythmia Retrospective Trial","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2021-04-29","conditions":"Alternating Hemiplegia of Childhood","enrollment":20},{"nctId":"NCT05720598","phase":"NA","title":"Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer","status":"UNKNOWN","sponsor":"Medical University of Lublin","startDate":"2022-11-04","conditions":"Gastric Cancer, Lymph Node Metastasis","enrollment":190},{"nctId":"NCT00354835","phase":"PHASE3","title":"Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2006-12-26","conditions":"Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma, Childhood Botryoid-Type Embryonal Rhabdomyosarcoma","enrollment":481},{"nctId":"NCT04020848","phase":"","title":"Observe Alternating Hemiplegia of Childhood (OBSERV-AHC) Study","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2019-10-28","conditions":"Alternating Hemiplegia","enrollment":34},{"nctId":"NCT04092764","phase":"NA","title":"Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2020-01-23","conditions":"Chemotherapy-induced Peripheral Neuropathy","enrollment":23},{"nctId":"NCT00145600","phase":"PHASE2","title":"Therapy for Pediatric Hodgkin Lymphoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2000-03-02","conditions":"Hodgkin Lymphoma","enrollment":296},{"nctId":"NCT03487016","phase":"PHASE2","title":"First-line Therapy in Metastatic PDAC","status":"UNKNOWN","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2019-02-15","conditions":"Metastatic Pancreatic Cancer","enrollment":270},{"nctId":"NCT02042391","phase":"PHASE2","title":"Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy","status":"COMPLETED","sponsor":"Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH","startDate":"2015-02-03","conditions":"Posttransplant Lymphoproliferative Disorder","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":211,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Alternating chemotherapy","genericName":"Alternating chemotherapy","companyName":"PETHEMA Foundation","companyId":"pethema-foundation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Alternating chemotherapy uses sequential administration of different chemotherapeutic agents to overcome drug resistance and improve treatment efficacy. Used for Acute leukemia (likely acute myeloid leukemia, based on PETHEMA Foundation focus).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}